Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 736 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

Table of Contents
Year : 2016  |  Volume : 20  |  Issue : 4  |  Page : 546-551

Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?

1 North Delhi Diabetes Centre, New Delhi, India
2 Sri Balaji Action Medical Institute, New Delhi, India

Date of Web Publication3-Jun-2016

Correspondence Address:
Rajeev Chawla
North Delhi Diabetes Centre, Rohini, New Delhi - 110 085
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2230-8210.183480

Rights and Permissions

Diabetes and related complications are associated with long-term damage and failure of various organ systems. The line of demarcation between the pathogenic mechanisms of microvascular and macrovascular complications of diabetes and differing responses to therapeutic interventions is blurred. Diabetes induces changes in the microvasculature, causing extracellular matrix protein synthesis, and capillary basement membrane thickening which are the pathognomic features of diabetic microangiopathy. These changes in conjunction with advanced glycation end products, oxidative stress, low grade inflammation, and neovascularization of vasa vasorum can lead to macrovascular complications. Hyperglycemia is the principal cause of microvasculopathy but also appears to play an important role in causation of macrovasculopathy. There is thought to be an intersection between micro and macro vascular complications, but the two disorders seem to be strongly interconnected, with micro vascular diseases promoting atherosclerosis through processes such as hypoxia and changes in vasa vasorum. It is thus imperative to understand whether microvascular complications distinctly precede macrovascular complications or do both of them progress simultaneously as a continuum. This will allow re-focusing on the clinical issues with a unifying perspective which can improve type 2 diabetes mellitus outcomes.

Keywords: Complications, diabetes, macrovascular, microvascular

How to cite this article:
Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J Endocr Metab 2016;20:546-51

How to cite this URL:
Chawla A, Chawla R, Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J Endocr Metab [serial online] 2016 [cited 2020 Oct 24];20:546-51. Available from: https://www.ijem.in/text.asp?2016/20/4/546/183480

   Introduction Top

Diabetes mellitus (DM) has routinely been described as a metabolic disorder characterized by hyperglycemia that develops as a consequence of defects in insulin secretion, insulin action, or both. Type 2 diabetes encompasses individuals who have insulin resistance (IR) and usually relative (rather than absolute) insulin deficiency.[1] The pathologic hallmark of DM involves the vasculature leading to both microvascular and macrovascular complications.[2] Chronicity of hyperglycemia is associated with long-term damage and failure of various organ systems mainly affecting the eyes, nerves, kidneys, and the heart.[1]

According to diabetes atlas (7th edition), the global prevalence of diabetes is estimated at 415 million (8.8%), which is predicted to rise to 642 million in next 25 years.[3] In India, there are about 69.2 million people with diabetes and are expected to cross 123.5 million by 2040.[3] Moreover, worldwide approximately 193 million diabetics remain undiagnosed predisposing them to the development of several long-term complications of untreated chronic hyperglycemia.[3] Although intensive glycemic control lowers the incidence and progression of microvascular complications, the morbidity associated with these complications is still increasing.[4] Several landmark studies such as the United Kingdom Prospective Diabetes Study (UKPDS) have demonstrated that strict glycemic control does limit microvascular disease while attempts to improve macrovascular outcomes through glucose-lowering interventions still remain shrouded with controversy. A relative risk (RR) reduction in myocardial infarction (MI) (P = 0.052) has been observed in the 10 years of posttrial follow-up of UKPDS.[5] Similarly, the risk of cardiovascular mortality, nonfatal MI and stroke reduced with pioglitazone in the Prospective Pioglitazone Clinical Trial in Macrovascular Events as compared to placebo group.[6] The action in diabetes and vascular disease: Preterax and Diamicron MR Controlled Evaluation and the Veterans Affairs Diabetes Trial failed to show any significant improvement in cardiovascular risk with the intensification of diabetes therapy.[7],[8] To further complicate matters, in Action to Control Cardiovascular Risk in Diabetes trial the use of intensive therapy for 3.5 years increased mortality but did not significantly reduce major cardiovascular events.[9]

In recent years, much attention has been focused on the management of macrovascular complications such as stroke and acute coronary syndromes. It is well-recognized that vascular complications in a given tissue are often accompanied by evidence of pathology in other vascular territories. A linear relationship between microvascular complications and duration of disease was established by the authors where they documented the presence of microvasculopathy across different age groups in their study in 25–40% of diabetic patients aged >25 years with more than 5 years duration of diabetes.[10] Researchers such as Krentz et al. and Al-Wakeel et al. have observed that both microvascular and macrovascular complications develop simultaneously in diabetes.[11],[12] On the contrary, Matheus and Gomes described the case report of type 1 DM (T1DM) patient with early and aggressive coronary artery disease (CAD) without evidence of nephropathy, retinopathy, or classical risk factors for CAD.[13] Thus, there is not much clarity over whether microvascular complication precedes macrovascular complications or they progress simultaneously.

The present review attempts an insight into this delicate relationship between microvascular and macrovascular complications of diabetes to understand whether they are discrete entities or in continuum with each other. We propose a unique continuum bridging the microvascular and the macrovascular risk which is based on our evidence-based studies consistently over a decade.

   Pathophysiological Basis of Micro Versus Macrovascular Complications Top

Patients with DM and associated microvascular complications appear particularly at higher risk of accelerated atherosclerosis which ultimately culminates in cerebrovascular and cardiovascular events and premature death.[14] Microvessels are the basic functional unit of the cardiovascular system comprising of arterioles, capillaries, and venules.[2] They differ from macrovessels in both their architecture and cellular components. In contrast to macrovessels supplying blood to organs, microvessels play important roles in maintaining blood pressure and proper nutrient delivery.[2] The microcirculation also has regulatory systems controlling vascular permeability and myogenic responses that can adapt blood flow according to local metabolic needs. Alteration in microvascular function may arise even before overt hyperglycemia and vascular pathologic changes manifest. Diabetes induces pathognomonic changes in the microvasculature, affecting the capillary basement membrane including arterioles in the glomeruli, retina, myocardium, skin, and muscle, by increasing their thickness, leading to the development of diabetic microangiopathy. This thickening eventually leads to abnormality in vessel function, inducing multiple clinical problems such as hypertension, delayed wound healing, and tissue hypoxia. Similarly, neovascularization arising from the vasa vasorum may interconnect macro-and microangiopathy, predict platelet rupture and promote atherosclerosis. The role of microvascular pathology in systemic diabetic complications, including macrovascular atherosclerosis, remains a subject for further debate.[2]

   Intersection of Microvascular and Macrovascular Complications of Diabetes: Evidence-Based Proof of Concept Top

Diabetic retinopathy

The risk of development of diabetic retinopathy (DR) in patients with (T2DM) has been found to be related to both severities of hyperglycemia and presence of hypertension. Fong et al. attributed approximately 10,000 new cases of blindness to DR in the United States.[15] In India, The Chennai Urban Rural Epidemiology Study (CURES) reported an overall DR prevalence of 17.6% (confidence interval [95% CI]: 15.8–19.5) in the diabetic population.[16] More recently, the Sankara Nethralaya DR Epidemiology and Molecular Genetic Study has estimated an urban prevalence of 18.0% (95% CI: 16.0–20.1) and a rural prevalence of 10.3% (95% CI: 8.53–11.97%) of DR in South India.[17],[18] Similar to this, Aravind Comprehensive Eye Study has reported 10.5% prevalence of DR (in self-reported subjects with diabetes) in the rural South Indian population.[19] A DR prevalence of 21.2% has been reported by Chawla et al. in their cohort of North Indian patients. This study also found a significant association between HbA1c, body mass index, duration of diabetes and microalbuminuria in the development of DR (P = 0.001).[20]

Several studies have explored the association between DR and macrovascular complications. As retinal microvasculature shares embryologic and anatomic characteristics with that of cerebral circulation, researchers have studied retinal abnormalities to provide clues to understand the underlying pathophysiology of different cerebrovascular diseases.[21] In the World Health Organization Multinational Study of Vascular Disease in Diabetes, retinopathy was related to the incidence of MI and death from cardiovascular disease (CVD).[22] In the Atherosclerosis Risk in Communities study, increased incidence of clinical stroke was associated with retinal microvascular abnormalities and generalized arteriolar narrowing.[23] Furthermore, retinopathy was significantly associated with combined stroke events (RR 1.7, 95% CI: 1.0–2.8) in persons without diabetes after controlling for age, sex, and systolic blood pressure. This association was stronger in those with two or more retinal microvascular signs (RR 2.7, CI: 1.5–5.2).[24] Targher et al. followed up 2103 T2DM outpatients for 7 years and found a remarkably increased risk of incident CVD in patients with proliferative/laser-treated retinopathy (hazard ratio 2.08 [1.02–3.7] for men and 2.41 [1.05–3.9] for women), after adjustment of hypertension and advanced nephropathy.[25] Contrary to this, Matheus and Gomes has reported cardiovascular events without any presence of retinopathy.[13]

Diabetic nephropathy

Proteinuria occurs in 15–40% of patients with type 1 diabetes while it ranges from 5 to 20% in patients with T2DM.[26] According to the European Diabetes Prospective Complications Study, the cumulative incidence of microalbuminuria was 12.6% over 7.3 years in patients with T1DM.[26] However, 18 years follow-up study from Denmark reported a prevalence rate of 33% in the T1DM population.[27] Similarly, in the (UKPDS), T2DM patients showed a 2.0% incidence of microalbuminuria per year, which reached up to 25% in 10 years postdiagnosis.[28] The prevalence of diabetic nephropathy was higher in African Americans, Asians, and Native Americans than Caucasians.[26] In India, CURES 45 reported a prevalence of 2.2% for overt diabetic nephropathy and 26.9% for microalbuminuria.[29]

The association of intense control to reduced microvascular complication, as reported by the Diabetes Control and Complications Trial, has emerged as a strong proof of concept for hyperglycemia being an important modifiable risk factor for diabetic nephropathy. A reduction in 10 mm Hg of systolic blood pressure is associated with a 13% decrease in the microvascular complications with minimal risk in patient with a systolic pressure <120 mm Hg.[30] Dyslipidemia with increased low-density lipoprotein (LDL) cholesterol and triglycerides is independently associated with diabetic kidney disease.[31]

The pathogenic mechanisms underlying diabetic nephropathy involve generation of reactive oxygen species (ROS), accumulation of advanced glycation end product (AGE), and activation of intracellular signaling molecules such as protein kinase C (PKC).[32],[33] A strong association between diabetic nephropathy and retinopathy was demonstrated by Arora et al. in 2004–2005 in 50 newly diagnosed patients with diabetes.[34] The direct association between the presence of microalbuminuria and macrovascular complications has also been well-established in many studies.[35] In an observational study, Hägg et al(2013). reported the increased incidence of both cerebral infarction and cerebral hemorrhage in patients with severe DR (SDR) and advanced diabetic nephropathy in 4083 patients with T1DM with 36,680 person-years of follow-up. Both nephropathy and SDR were found to be independently increasing the risk for all subtypes of stroke.[36] The increased incidence of stroke in diabetic nephropathy has also been reiterated in the Pittsburgh Epidemiology of Diabetes Complications study, where overt nephropathy increases the risk of ischemic stroke 4.4-fold (but not the risk for hemorrhagic stroke, probably due to the insufficient number of samples).[36] Retinopathy and macroalbuminuria produce higher rates of cardiovascular events among Chinese patients.[37]

Diabetic neuropathy

Diabetic neuropathy, a life-threatening complication involves both peripheral and autonomic nerves, affecting almost half of the diabetic population.[38] The risk of development of diabetic neuropathy is directly proportional to both the duration and magnitude of hyperglycemia. In addition, some individuals may also possess genetic facets that influence their predisposition in developing such complications.[35] The prevalence of diabetic neuropathy varies from country to country. In India, a high prevalence (29.2%) of diabetic peripheral neuropathy was reported among the North Indian population.[39] Further studies in North Indian region (Lucknow) and North-eastern region (Imphal) revealed a prevalence of 29.2% and 29.0%, respectively, among newly diagnosed diabetic patients (duration <6 months).[40],[41] Chawla et al. reported the prevalence of 15.3% in their study involving 720 North Indian patients from New Delhi.[20]

Although the precise nature of the injury to the peripheral nerves from hyperglycemia is not yet certain, the mechanisms of hyperglycemia-induced polyol pathway, injury from AGEs, and enhanced oxidative stress have been implicated in its pathogenesis. The damage to peripheral nerves may be mediated by effects on nerve tissue or by endothelial injury or vascular dysfunction.[2] Peripheral neuropathy in diabetes appears in several forms depending on the site, manifesting as sensory, focal/multifocal, and autonomic neuropathies. Diabetic neuropathy has resulted in more than 80% amputations after foot ulceration or injury.[35]

A study conducted by Miguel et al. demonstrated a significant correlation between diabetic neuropathy and the existence of one or more macrovascular complications showing that diabetic patients with peripheral neuropathy presented with significantly higher rates of cardiac events and peripheral vascular disease (PVD) than diabetic patients without neuropathy. Strokes were also numerically higher in the neuropathy group.[42] Chawla et al. in 2011–2012 demonstrated an association between diabetic neuropathy and development of DR and microalbuminuria in 855 patients.[43] Diabetic cardiac autonomic neuropathy have been found to have a strong co-association with DR (22% vs. 14.3%), diabetic neuropathy (14% vs. 6.8%), and poor glycemic control.

Hence, it is recommended to evaluate autonomic nervous system function at the time of T2DM diagnosis and annually thereafter.[44] Chawla et al. established a positive correlation between autonomic neuropathy and peripheral neuropathy (P = 0.00014); however, the further association between autonomic neuropathy and PVD failed to reach statistical significance.[45] In addition, a direct relationship of lower extremity arterial disease (LEAD) with T2DM was also documented by Chawla et al. They found symptoms of peripheral vascular insufficiency or weak peripheral vessels in 13.8% of patients with foot Doppler confirmed the prevalence of LEAD in 7.4% of patients.[46] The authors validated and advocate the use of neuropathy symptoms score and neuropathy disability score in the clinical and bedside diagnosis of peripheral neuropathy.[47]

   Common Pathways for Development of Both Micro and Macrovascular Complications Top

Advanced glycation products

AGEs are a heterogeneous group of molecules formed by the nonenzymatic glycation of plasma proteins causing a disruption in their normal functioning by altering their molecular conformation, disrupting enzyme activity, and interfering with receptor functioning. AGEs accumulate in different types of cells and affect their extracellular and intracellular structure and function by cross-linking not only with proteins but also lipids and nucleic acids contributing to a variety of diabetic complications.[48] AGEs crosslink with plasma membrane-localized receptors for AGEs (RAGE) leading to up-regulation of transcription factors such as nuclear factor-κB and its target genes, release of pro-inflammatory molecules and free radicals. Soluble AGEs activate monocytes, and AGEs in the basement membrane inhibit monocyte migration. AGE-bound RAGE increases endothelial permeability to macromolecules. AGEs block nitric oxide activity in the endothelium and cause the production of ROS.[49]

Further, AGEs modify LDL particles and together with vascular damage accelerate atherosclerosis.[50] Kalousová et al. found significant elevation of AGE in patients with T2DM as compared to both healthy (5.11 ± 1.15 × 103 AU/g vs. 4.08 ± 0.71 × 103 AU/g, P < 0.001) as well as T1DM patients (4.14 ± 0.86 × 103 AU/g, P < 0.005).[51] Kilhovd et al. demonstrated a significant increase in the levels of AGEs in patients with T2DM compared with nondiabetic control subjects (7.4 [4.4–10.9] vs. 4.2 [1.6–6.4] U/ml, P < 0.0001). Besides, they also found elevated levels of AGE in patients with coronary heart disease (CHD) than those of without CHD (8.1 [6.4–10.9] vs. 7.1 [3.5–9.8] U/ml, P = 0.03) in patients with T2DM.[52]

Oxidative stress

Oxidative stress, caused by the overproduction of ROS plays an important role in the activation of other pathogenic pathways involved in diabetic complications, including elevated polyol pathway activity, nonenzymatic glycation, and PKC levels which in turn lead to the development of micro-and macrovascular complications.[53] It also inactivates two critical anti-atherosclerotic enzymes, endothelial nitric oxide synthase, and prostacyclin synthase.[54] Hyperglycemia promotes the formation of ROS, which interacts with both deoxyribonucleic acid (DNA) and proteins, causing cellular damage, especially targeting mitochondrial DNA. A study on the human retinal endothelial cell (EC) demonstrated very early mitochondrial DNA damage with hyperglycemia-induced overproduction of ROS.[55] ROS-mediated cellular damage may be a form of pathologic “memory” in the microvasculature that persists even after glucose normalization. Several experimental evidences point to mitochondrial superoxide overproduction as the major culprit in the development of metabolic abnormalities in diabetics.[56] IR induces mitochondrial ROS production from free fatty acids and inhibits anti-atherosclerotic enzymes causing atherosclerosis and cardiomyopathy in T2DM patients. In subjects without diabetes or impaired glucose tolerance, those in the highest quintile of IR had a 2.0-fold increase in CVD risk compared to those in the lowest quintile after adjusting several known cardiovascular risk factors, including LDL, triglycerides, high-density lipoprotein, systolic blood pressure, and smoking.[57]

The other pathways implicated in diabetic complications such as AGE formation, PKC activation, increased polyol flux, and hexosamine formation are also linked to oxidative stress in promoting macrovascular complications through multiple mechanisms. Increased glucose concentrations can activate nuclear factor-κB, a key mediator that regulates multiple pro-inflammatory and pro-atherosclerotic target genes in vascular smooth muscle cells (VSMCs), ECs, and macrophages.[55] Hyperglycemia itself stimulates oxidative stress, which indeed acts as a driving force in accelerated atherosclerosis.

Low-grade inflammation

Inflammation has been recognized as one of the potent risk factors in both atherosclerosis and T2DM. Vascular cells encounter many early pathologic changes in response to hyperglycemia, causing a loss of nonadhesive property and adhesion of monocyte to ECs, which is an early step in atherogenesis. Hyperglycemia has been reported to provoke monocyte adhesion to arterial ECs.[58] The association between hyperglycemia and AGEs with oxidative stress is manifested as both can stimulate EC production of superoxide [Figure 1]. Glucose also activates matrix-degrading enzyme metalloproteinase which causes plaque rupture and arterial remodeling as well as VSMC proliferation, migration and altered activity. The role of increased level of tumor necrosis factor alpha in the development of IR is well-documented. IR itself has inflammatory action as described above. The levels of several other inflammatory markers such as C-reactive protein, fibrinogen, plasminogen activator inhibitor I, and interleukine-6 have been shown to increase with the onset of diabetes. Monocyte activation has been documented in the presence of high glucose with induction of inflammatory mediators such as PKC and nuclear factor-κB promoting oxidative stress.[59]
Figure 1: Insulin resistance and hyperglycemia drive the atherosclerotic process

Click here to view

Neovascularization of vasa vasorum

The proliferation of vasa vasorum is associated with increased plaque burden, which subsequently promotes atherosclerosis.[60] Many cellular processes such as inflammation, plaque perfusion and concomitant intra-plaque hemorrhage are critical during the development of atherosclerotic plaques and are linked with vasa vasorum proliferation. Neovascularization develops by the growth from both adventitial layer (outward) and arterial lumen (inward) toward the intima.[61] In T2DM, plaque rupture is associated with increased angiogenesis, and diabetic atherosclerosis is further accelerated by neovasculature microangiopathy.[62] The initial angiogenic response in the adventitial vasa vasorum, an important component of homeostatic mechanisms, appears to be stimulated by hypoxia through identification of increased hypoxia-inducible factor and vascular endothelial growth factor (VEGF) action.[63]

VEGF, a multifunctional cytokine, also contributes to microvascular complications by increasing the vascular permeability to macromolecules, monocyte chemotaxis, and tissue factor production.[64] Up-regulation of VEGF is also reported in experimental diabetic kidney disease models. However, contrary to this, VEGF treatment has been shown to restore microcirculation in the vasa nervorum and limit diabetic neuropathy as demonstrated by rodent VEGF gene transfer experiment.[2] In the eye, a neurotropic factor-pigment epithelium-derived factor (PEDF) may offset VEGF action by its potent angiogenic inhibition.[65] PEDF level is decreased in proliferative DR, whereas VEGF levels are increased. Decreased PEDF levels may also likely contribute to diabetic nephropathy. Other growth factors such as insulin-like growth factor 1, basic fibroblast growth factor, and hepatocyte growth factor may foster proliferative retinopathy.[66]

   Microvascular and Macrovascular Complications-Continuum or Separate: The Debate Continues Top
[Figure 2]
Figure 2: The diabetes continuum

Click here to view

Heart involvement in diabetes may not be only a macrovascular disease where there is Orchestra of contributing factors to the development of diabetic cardiomyopathy concerning fatty acid and glucose complex structural macrovascular derangements such as hypertrophy and loss of function due to glycation but also a microvascular involvement following “common soil” hypothesis of diabetes complications. Atherosclerosis in large arteries as well as cardiomyopathy in diabetes a microvascular component may go hand in hand.[67]

Therefore, changes in small arteries and capillaries are not responsible for only microvascular long-term complications in patients with diabetes (retinopathy, nephropathy, and neuropathy) but also for other manifestations of heart disease in diabetes.

This review highlights the need for implementing programs for early detection, screening, and awareness to mitigate the burden of managing the complications.

Good blood glucose control improves microvascular disease and should be implemented early and maintained for the optimum length of time. Appropriate controls of blood pressure as well as dyslipidemia are extremely important in macrovascular disease prevention besides glycemic control. Patients with microvascular complications appear particularly prone to accelerated atherosclerosis and premature death. Neovascularization arising from the vasa vasorum may interconnect macro-and microangiopathy.

A clearer picture on differing responses to therapeutic interventions could lead to better management and improve T2DM outcomes not only regarding microvascular but also macrovascular complications as well. Further systematic research on the above interlinking hypothesis will help us get more clarity whether microvascular complications precede macrovascular complications or they are two ends of the same spectrum of disease existing in continuum.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Standards of medical care in diabetes-2016: Summary of revisions. Diabetes Care 2016;39 Suppl 1:S4-5.  Back to cited text no. 1
Orasanu G, Plutzky J. The pathologic continuum of diabetic vascular disease. J Am Coll Cardiol 2009;53 5 Suppl:S35-42.  Back to cited text no. 2
International Diabetes Federation. IDF Atlas. 7th edition. Available from: http://www.diabetesatlas.org. [Last accessed on 2015 Dec 27].  Back to cited text no. 3
ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.  Back to cited text no. 4
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.  Back to cited text no. 5
Charbonnel B, Dormandy J, Erdmann E, Massi-Benedetti M, Skene A; PROactive Study Group. The prospective pioglitazone clinical trial in macrovascular events (PROactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Diabetes Care 2004;27:1647-53.  Back to cited text no. 6
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39.  Back to cited text no. 7
Patel A, Chalmers J, Poulter N. ADVANCE: Action in diabetes and vascular disease. J Hum Hypertens 2005;19 Suppl 1:S27-32.  Back to cited text no. 8
Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr., Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.  Back to cited text no. 9
Chawla A, Chawla R, Bhasin GK, Soota K. Profile of adolescent diabetics in North Indian population. J Clin Diabetol 2014;1:1-3.  Back to cited text no. 10
Krentz AJ, Clough G, Byrne CD. Interactions between microvascular and macrovascular disease in diabetes: Pathophysiology and therapeutic implications. Diabetes Obes Metab 2007;9:781-91.  Back to cited text no. 11
Al-Wakeel JS, Hammad D, Al Suwaida A, Mitwalli AH, Memon NA, Sulimani F. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic. Saudi J Kidney Dis Transpl 2009;20:77-85.  Back to cited text no. 12
[PUBMED]  Medknow Journal  
Matheus AS, Gomes MB. Early aggressive macrovascular disease and type 1 diabetes mellitus without chronic complications: A case report. BMC Res Notes 2013;6:222.  Back to cited text no. 13
Kalofoutis C, Piperi C, Kalofoutis A, Harris F, Phoenix D, Singh J. Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches. Exp Clin Cardiol 2007;12:17-28.  Back to cited text no. 14
Fong DS, Aiello LP, Ferris FL 3rd, Klein R. Diabetic retinopathy. Diabetes Care 2004;27:2540-53.  Back to cited text no. 15
Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328-33.  Back to cited text no. 16
Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009;116:311-8.  Back to cited text no. 17
Raman R, Ganesan S, Pal SS, Kulothungan V, Sharma T. Prevalence and risk factors for diabetic retinopathy in rural India. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study III (SN-DREAMS III), report no 2. BMJ Open Diabetes Res Care 2014;2:e000005.  Back to cited text no. 18
Nirmalan PK, Tielsch JM, Katz J, Thulasiraj RD, Krishnadas R, Ramakrishnan R, et al. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: The Aravind Comprehensive Eye Survey. Invest Ophthalmol Vis Sci 2005;46:2308-12.  Back to cited text no. 19
Chawla A, Chawla R, Chawla A. Correlation Between Retinopathy Microalbuminuria and Other Modifiable Risk Factors. Presented on American Diabetes Association's 75th Scientific Session; June 5-9; Boston, Massachusetts; 2015.  Back to cited text no. 20
Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, et al. Retinal microvascular abnormalities and incident stroke: The atherosclerosis risk in communities study. Lancet 2001;358:1134-40.  Back to cited text no. 21
Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: The WHO mutinational study of vascular disease in diabetes. Diabetologia 2001;44 Suppl 2:S54-64.  Back to cited text no. 22
Yatsuya H, Folsom AR, Wong TY, Klein R, Klein BE, Sharrett AR; ARIC Study Investigators. Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis risk in communities study. Stroke 2010;41:1349-55.  Back to cited text no. 23
Mitchell P, Wang JJ, Wong TY, Smith W, Klein R, Leeder SR. Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 2005;65:1005-9.  Back to cited text no. 24
Targher G, Bertolini L, Zenari L, Lippi G, Pichiri I, Zoppini G, et al. Diabetic retinopathy is associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabet Med 2008;25:45-50.  Back to cited text no. 25
Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: Diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-76.  Back to cited text no. 26
Soedamah-Muthu SS, Chaturvedi N, Witte DR, Stevens LK, Porta M, Fuller JH; EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: The EURODIAB prospective complications study (PCS). Diabetes Care 2008;31:1360-6.  Back to cited text no. 27
Hovind P, Tarnow L, Rossing P, Jensen BR, Graae M, Torp I, et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: Inception cohort study. BMJ 2004;328:1105.  Back to cited text no. 28
Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR; UKPDS Group. Development and progression of nephropathy in type 2 diabetes: The United Kingdom prospective diabetes study (UKPDS 64). Kidney Int 2003;63:225-32.  Back to cited text no. 29
Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: The Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007;30:2019-24.  Back to cited text no. 30
Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ 2000;321:412-9.  Back to cited text no. 31
Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease. J Am Soc Nephrol 2006;17 4 Suppl 2:S145-7.  Back to cited text no. 32
Cade WT. Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 2008;88:1322-35.  Back to cited text no. 33
Arora GS, Chawla R, Ahuja CP. To Evaluate the Clinical Profile and Determine the Prevalence of Complications in Newly Detected Type-2 Diabetes Patients. Presented on Research Society for the Study of Diabetes in India's (RSSDI) 33rd Annual Conference; September 23rd-25th, Bangalore; 2005.  Back to cited text no. 34
Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26:77-82.  Back to cited text no. 35
Hägg S, Thorn LM, Putaala J, Liebkind R, Harjutsalo V, Forsblom CM, et al. Incidence of stroke according to presence of diabetic nephropathy and severe diabetic retinopathy in patients with type 1 diabetes. Diabetes Care 2013;36:4140-6.  Back to cited text no. 36
Lloyd CE, Klein R, Maser RE, Kuller LH, Becker DJ, Orchard TJ. The progression of retinopathy over 2 years: The Pittsburgh epidemiology of diabetes complications (EDC) study. J Diabetes Complications 1995;9:140-8.  Back to cited text no. 37
Tong PC, Kong AP, So WY, Ng MH, Yang X, Ng MC, et al. Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in chinese patients with type 2 diabetes. Diabetes Care 2006;29:2439-44.  Back to cited text no. 38
Tapp R and Shaw J. Epidemiology of diabetic neuropathy. In: Tesdaye S, Boulton A, eds. Oxford, UK: Oxford University Press; 2009.  Back to cited text no. 39
Bansal D, Gudala K, Muthyala H, Esam HP, Nayakallu R, Bhansali A. Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig 2014;5:714-21.  Back to cited text no. 40
Dutta A, Naorem S, Singh TP, Wangjam K. Prevalence of peripheral neuropathy in newly diagnosed type 2 diabetics. Int J Diabetes Dev Ctries 2005;25:30-3.  Back to cited text no. 41
Miguel GA, Fernández EG, Rodríguez JCR, Pablos DL, Díaz-Guerra GM, Hawkins FG. Association Between Peripheral Neuropathy and Macrovascular Disease in Diabetic Patients. Presented at Endocrine Society's 97th Annual Meeting and Expo, March 5-8; San Diego; 2015.  Back to cited text no. 42
Chawla R, Rathore P, editor. To Study the Prevalence of Diabetic Peripheral Neuropathy by Biothesiometric Evaluation & It's Co-association with Other Complications 2004(NNDU Proceedings 2004); 2004.  Back to cited text no. 43
Chawla R, Poddar A, Chawla R. High Prevalence of CAN in New Onset T-2 Diabetes Patients. Presented on American Diabetes Association's 68th Scientific Session; June 8; San Francisco, CA; 2008.  Back to cited text no. 44
Chawla R, Gupta S, Punyani H. Correlation Between Autonomic Neuropathy and Distal Peripheral Neuropathy and Its Co-association with Peripheral Vascular Disease in Type-2 Diabetes Mellitus Patients. Presented on American Diabetes Association's 70th Scientific Session; June 25; Orlando, FL, USA; 2010.  Back to cited text no. 45
Chawla R, Rathore P. Evaluation of Lower Extremity Arterial Disease (LEAD/PVD) in Type-2 Diabetics and Its Co-association with Other Macro Vascular Complications. Presented on Annual Conference of Diabetic Foot Society of India's Scientific Session; September 4-5; Bhopal, India; 2004.  Back to cited text no. 46
Chawla A, Bhasin GK, Chawla R. Validation of neuropathy symptoms score (NSS) and neuropathy disability score (NDS) in the clinical diagnosis of peripheral neuropathy in middle aged people with diabetes. Internet J Fam Pract 2013;12:1.  Back to cited text no. 47
Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 2014;18:1-14.  Back to cited text no. 48
Schmidt AM, Hori O, Brett J, Yan SD, Wautier JL, Stern D. Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb 1994;14:1521-8.  Back to cited text no. 49
Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 2006;114:597-605.  Back to cited text no. 50
Kalousová M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51:597-604.  Back to cited text no. 51
Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 1999;22:1543-8.  Back to cited text no. 52
Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 2004;53:131-42.  Back to cited text no. 53
Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: Avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev 2011;7:313-24.  Back to cited text no. 54
Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010;107:1058-70.  Back to cited text no. 55
Xie L, Zhu X, Hu Y, Li T, Gao Y, Shi Y, et al. Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs. Invest Ophthalmol Vis Sci 2008;49:4203-9.  Back to cited text no. 56
Duncan JG. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 2011;1813:1351-9.  Back to cited text no. 57
Syed Ikmal SI, Zaman Huri H, Vethakkan SR, Wan Ahmad WA. Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. Int J Endocrinol 2013;2013:698567.  Back to cited text no. 58
Otsuka A, Azuma K, Iesaki T, Sato F, Hirose T, Shimizu T, et al. Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta. Diabetologia 2005;48:2667-74.  Back to cited text no. 59
Tian J, Hu S, Sun Y, Yu H, Han X, Cheng W, et al. Vasa vasorum and plaque progression, and responses to atorvastatin in a rabbit model of atherosclerosis: Contrast-enhanced ultrasound imaging and intravascular ultrasound study. Heart 2013;99:48-54.  Back to cited text no. 60
Hayden MR, Tyagi SC. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: A malignant transformation. Cardiovasc Diabetol 2004;3:1.  Back to cited text no. 61
Patel A. Does the role of angiogenesis play a role in atherosclerosis and plaque instability. Anat Physiol 2014;4:147.  Back to cited text no. 62
Xu J, Lu X, Shi GP. Vasa vasorum in atherosclerosis and clinical significance. Int J Mol Sci 2015;16:11574-608.  Back to cited text no. 63
Bonnefond A, Saulnier PJ, Stathopoulou MG, Grarup N, Ndiaye NC, Roussel R, et al. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications? PLoS One 2013;8:e55921.  Back to cited text no. 64
Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest 2001;107:1083-92.  Back to cited text no. 65
Gao G, Li Y, Zhang D, Gee S, Crosson C, Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 2001;489:270-6.  Back to cited text no. 66
Laakso M. Heart in diabetes: A microvascular disease. Diabetes Care 2011;34 Suppl 2:S145-9.  Back to cited text no. 67


  [Figure 1], [Figure 2]

This article has been cited by
1 Molecular complexities underlying the vascular complications of diabetes mellitus – A comprehensive review
Shalini Paul,Azam Ali,Rajesh Katare
Journal of Diabetes and its Complications. 2020; : 107613
[Pubmed] | [DOI]
2 Baicalin attenuates Fibrogenic process in human renal proximal tubular cells (HK-2) exposed to diabetic Milieu
Jung Eun Nam,So Yeon Jo,Chul Woo Ahn,Yu Sik Kim
Life Sciences. 2020; : 117742
[Pubmed] | [DOI]
3 RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Rajeev Chawla,SV Madhu,BM Makkar,Sujoy Ghosh,Banshi Saboo,Sanjay Kalra
Indian Journal of Endocrinology and Metabolism. 2020; 24(1): 1
[Pubmed] | [DOI]
4 Reduction of hepatorenal and pancreatic damage by Ferula elaeochytris extract in STZ induced diabetic rats
Ahmet Uyar,Turan Yaman,Omer Faruk Keles,Elif Ebru Alkan,Abdulbaki Demir,Ismail Celik,Zabit Yener
Biotechnic & Histochemistry. 2020; : 1
[Pubmed] | [DOI]
5 Ginkgo Biloba Extract in Ophthalmic and Systemic Disease, With a Focus on Normal-Tension Glaucoma
Margarita Labkovich,Erica B. Jacobs,Siddharth Bhargava,Louis R. Pasquale,Robert Ritch
Asia-Pacific Journal of Ophthalmology. 2020; 9(3): 215
[Pubmed] | [DOI]
6 Potential risks of endoplasmic reticulum stress on vasculopathy in diabetes
Sagir Mustapha,Mustapha Mohammed,Ismaeel Yunusa,Aida Hanum Ghulam Rasool,Siti Safiah Mokhtar
Obesity Medicine. 2020; 19: 100274
[Pubmed] | [DOI]
7 Additive Effect of Topical Nepafenac on Mydriasis in Patients With Diabetes Mellitus
Hasan Kiziltoprak,Mustafa Koc,Esat Yetkin,Kemal Tekin,Merve Inanc,Kemal Ozulken
Eye & Contact Lens: Science & Clinical Practice. 2020; 46(5): 310
[Pubmed] | [DOI]
8 Does Periodontal Inflammation Affect Type 1 Diabetes in Childhood and Adolescence? A Meta-Analysis
Biagio Rapone,Massimo Corsalini,Ilaria Converti,Maria Teresa Loverro,Antonio Gnoni,Paolo Trerotoli,Elisabetta Ferrara
Frontiers in Endocrinology. 2020; 11
[Pubmed] | [DOI]
9 The Growing Epidemic of Diabetes Mellitus
Dragan Lovic,Alexia Piperidou,Ioanna Zografou,Haralambos Grassos,Andreas Pittaras,Athanasios Manolis
Current Vascular Pharmacology. 2020; 18(2): 104
[Pubmed] | [DOI]
10 Association of glycaemia control, age and duration of morbidity with the quality of life in patients of type 2 diabetes mellitus attending the tertiary care hospital in field practice area of Ottapalam Palakad
Kumar Arjit,Amit Kumar Singh
Journal of Public Health and Epidemiology. 2020; 12(2): 136
[Pubmed] | [DOI]
11 A non-inferiority study to compare daily fast-acting insulin versus twice a week slow-acting insulin–moderate diabetes mode
Cristina Pires Camargo,Rafael Hori Nagamine Weschenfelder,Guilherme Moreira da Fonseca,Alexandre Agostinho da Cruz Sousa,Rolf Gemperli
Acta Cirurgica Brasileira. 2020; 35(7)
[Pubmed] | [DOI]
12 Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response
Monta Ustinova,Laura Ansone,Ivars Silamikelis,Vita Rovite,Ilze Elbere,Laila Silamikele,Ineta Kalnina,Davids Fridmanis,Jelizaveta Sokolovska,Ilze Konrade,Valdis Pirags,Janis Klovins,Tao Huang
PLOS ONE. 2020; 15(8): e0237400
[Pubmed] | [DOI]
13 Neuroprotective effects of mango cv. ‘Ataulfo’ peel and pulp against oxidative stress in streptozotocin-induced diabetic rats
Rosario Cázares-Camacho,J. Abraham Domínguez-Avila,Humberto Astiazarán-García,Marcelino Montiel-Herrera,Gustavo A. González-Aguilar
Journal of the Science of Food and Agriculture. 2020;
[Pubmed] | [DOI]
14 Multimodal a-Glucosidase and a-Amylase Inhibition and Antioxidant Effect of the Aqueous and Methanol Extracts from the Trunk Bark of Ceiba pentandra
Telesphore Benoit Nguelefack,Christian Kuete Fofie,Elvine Pami Nguelefack-Mbuyo,Adeline Kaptue Wuyt
BioMed Research International. 2020; 2020: 1
[Pubmed] | [DOI]
15 Changes in QTc and PR Intervals among Indian Type 2 Diabetes Patients with Respect to Prevailing Glycated Hemoglobin Level: a Retrospective Analysis
Sayak Roy,Guruprasad Bhattacharya,Mridul Bera
SN Comprehensive Clinical Medicine. 2020;
[Pubmed] | [DOI]
16 Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy
Inês Preguiça,André Alves,Sara Nunes,Pedro Gomes,Rosa Fernandes,Sofia D. Viana,Flávio Reis
Nutrients. 2020; 12(1): 250
[Pubmed] | [DOI]
17 Altered touch perception and associated risk factors in individuals with diabetes mellitus
Juliana Andreia Fernandes Noronha,Cissa Azevedo,Caroline de Castro Moura,Elaine Custódio Rodrigues Gusmão,Ana Carolina Lima Ramos Cardoso,Tânia Couto Machado Chianca
Revista Brasileira de Enfermagem. 2020; 73(6)
[Pubmed] | [DOI]
18 Diabetic retinopathy its genetics and single nucleotide polymorphism associated with multi-ethnic cohort – A review
R. Thiruchelvi,Kiruthiga Raghunathan
Materials Today: Proceedings. 2020;
[Pubmed] | [DOI]
19 Stem Cells: A Review Encompassing the Literature with a Special Focus on the Side-Lined Miraculous Panacea; Pre-Morula Stem Cells
Aryendu K. Saini,Rakesh Saini,Himanshu Bansode,Anurag Singh,Lalita Singh
Current Stem Cell Research & Therapy. 2020; 15(4): 379
[Pubmed] | [DOI]
20 RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
Rajeev Chawla,S. V. Madhu,B. M. Makkar,Sujoy Ghosh,Banshi Saboo,Sanjay Kalra
International Journal of Diabetes in Developing Countries. 2020; 40(S1): 1
[Pubmed] | [DOI]
21 Serum electrolytes levels in patients with type 2 diabetes mellitus: a cross-sectional study
Shridhar Reshma,Sushith Sushith,Mangalore Balakrishna Prathima,DæSa Janice,Gopal R Madan,Pragathi Gowda,Kiran PK Kumar,Mohandas Rai,Bhuvanesh Sukhlal Kalal
Diabetes mellitus. 2020; 23(3): 223
[Pubmed] | [DOI]
22 The protective effect of green tea on diabetes-induced hepato-renal pathological changes: a histological and biochemical study
Tarek Atia,Hader I. Sakr,Ahmed A. Damanhory,Karim Moawad,Moustfa Alsawy
Archives of Physiology and Biochemistry. 2020; : 1
[Pubmed] | [DOI]
23 Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway
Ye Chen,Rui Yan,Bo Li,Jun Liu,Xiaoxia Liu,Wenyu Song,Chunling Zhu
International Urology and Nephrology. 2020;
[Pubmed] | [DOI]
24 Role of Mitochondrial Stress Protein HSP60 in Diabetes-Induced Neuroinflammation
Donisha Shani Niharika Keembiya Liyanagamage,Ryan D. Martinus
Mediators of Inflammation. 2020; 2020: 1
[Pubmed] | [DOI]
25 Biocompatible fungal chitosan encapsulated phytogenic silver nanoparticles enhanced antidiabetic, antioxidant and antibacterial activity
Anbazhagan Sathiyaseelan,Kandasamy Saravanakumar,Arokia Vijay Anand Mariadoss,Myeong-Hyeon Wang
International Journal of Biological Macromolecules. 2020;
[Pubmed] | [DOI]
26 The relative risk of developing type 2 diabetes among individuals with prediabetes compared with individuals with normoglycaemia: Meta-analysis and meta-regression
Xin Yi Xu,Angela Yee Man Leung,Robert Smith,Janet Yuen Ha Wong,Pui Hing Chau,Daniel Yee Tak Fong
Journal of Advanced Nursing. 2020;
[Pubmed] | [DOI]
27 The neuroprotective effect of simvastatin on the cerebellum of experimentally-induced diabetic rats through klotho upregulation: An immunohistochemical study
Ola Mohammed Youssef,Amira Ibrahim Morsy,Mona A. El-Shahat,Amany M Shams,Samira Lotfy Abd-Elhady
Journal of Chemical Neuroanatomy. 2020; 108: 101803
[Pubmed] | [DOI]
28 Type 1 Diabetes in Youth and Technology-Based Advances in Management
Christopher Ferber,Catherine S. Mao,Jennifer K. Yee
Advances in Pediatrics. 2020;
[Pubmed] | [DOI]
29 Ethanol extract of Cissampelos sympodialis ameliorates lung tissue damage in streptozotocin-induced diabetic rats
Tessio David de Medeiros,Annyelly Tavares Pereira,Flavio Santos da Silva,Raul Hernandes Bortolin,Karinna Veríssimo Meira Taveira,Bento João da Graça Azevedo Abreu,Adriana Augusto de Rezende,Naisandra Bezerra da Silva Farias,José Maria Barbosa Filho,Karina Carla de Paula Medeiros
Brazilian Journal of Pharmaceutical Sciences. 2020; 56
[Pubmed] | [DOI]
30 Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial
Mala Dharmalingam,S. R. Aravind,Hemant Thacker,S. Paramesh,Brij Mohan,Manoj Chawla,Arthur Asirvatham,Ramesh Goyal,Jayashri Shembalkar,R. Balamurugan,Pradnya Kadam,Hansraj Alva,Rahul Kodgule,Monika Tandon,Sivakumar Vaidyanathan,Amol Pendse,Rajesh Gaikwad,Sagar Katare,Sachin Suryawanshi,Hanmant Barkate
Drugs. 2020;
[Pubmed] | [DOI]
31 Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment
Kepeng Ou,David A. Copland,Sofia Theodoropoulou,Sonja Mertsch,Youjian Li,Jian Liu,Stefan Schrader,Lei Liu,Andrew D. Dick
Journal of Cellular and Molecular Medicine. 2020;
[Pubmed] | [DOI]
32 Hyperbaric Oxygen Therapy and Vascular Complications in Diabetes Mellitus
Ivana Resanovic,Božidarka Zaric,Jelena Radovanovic,Emina Sudar-Milovanovic,Zoran Gluvic,Danimir Jevremovic,Esma R. Isenovic
Angiology. 2020; 71(10): 876
[Pubmed] | [DOI]
33 Autologous non-cultured keratinocyte cell suspension in non-healing diabetic ulcers: A preliminary study
Shruti Barnwal,Ravi Kant,Poonam Yadav
Journal of Family Medicine and Primary Care. 2020; 9(9): 4686
[Pubmed] | [DOI]
34 Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
Rakesh Kumar Sahay,Vinod Mittal,G Raja Gopal,Sunil Kota,Ghanshyam Goyal,Mahesh Abhyankar,Santosh Revenkar
Cureus. 2020;
[Pubmed] | [DOI]
35 Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-Associated Complications: A Systematic Review of Preclinical Studies
Phiwayinkosi V. Dludla,Sonia Silvestri,Patrick Orlando,Kwazi B. Gabuza,Sithandiwe E. Mazibuko-Mbeje,Tawanda M. Nyambuya,Vuyolwethu Mxinwa,Kabelo Mokgalaboni,Rabia Johnson,Christo J. F. Muller,Luca Tiano,Johan Louw,Bongani B. Nkambule
Nutrients. 2020; 12(3): 739
[Pubmed] | [DOI]
36 Subendothelial matrix as the playground for “diabetic milieu” factors in development of angiopathy
K. A. Nizheradze,A. I. Khoruzhenko
Biopolymers and Cell. 2020; 36(4): 245
[Pubmed] | [DOI]
37 A UHPLC-QTOF-MS screening provides new insights into the phytochemical composition and biological properties of six Consolida species from Turkey
Gabriele Rocchetti,Gokhan Zengin,Yavuz Selim Cakmak,Mohamad Fawzi Mahomoodally,Muhammed Fettah Kaya,Sarah Mohammed Alsheikh,Jasmina Glamocilja,Marina Sokovic,Devina Lobine,Luigi Lucini
Industrial Crops and Products. 2020; 158: 112966
[Pubmed] | [DOI]
38 Living Day to Day
Gerald Kayingo,Virginia McCoy Hass
Physician Assistant Clinics. 2020; 5(2): 213
[Pubmed] | [DOI]
39 Association between C reactive protein and microvascular and macrovascular dysfunction in sub-Saharan Africans with and without diabetes: the RODAM study
Charles Frederick Hayfron-Benjamin,Anke H Maitland-van der Zee,Bert-Jan van den Born,Albert G B Amoah,Karlijn A C Meeks,Kerstin Klipstein-Grobusch,Matthias B Schulze,Joachim Spranger,Ina Danquah,Liam Smeeth,Erik J A J Beune,Frank Mockenhaupt,Charles O Agyemang
BMJ Open Diabetes Research & Care. 2020; 8(1): e001235
[Pubmed] | [DOI]
40 Early Endothelial Dysfunction in Type 1 Diabetes Is Accompanied by an Impairment of Vascular Smooth Muscle Function: A Meta-Analysis
Elodie Lespagnol,Luc Dauchet,Mehdi Pawlak-Chaouch,Costantino Balestra,Serge Berthoin,Martin Feelisch,Matthieu Roustit,Julien Boissière,Pierre Fontaine,Elsa Heyman
Frontiers in Endocrinology. 2020; 11
[Pubmed] | [DOI]
41 Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
Linong Ji,Jianhua Ma,Weiping Lu,Jingdong Liu,Jiao’e Zeng,Jialin Yang,Wei Li,Xiuzhen Zhang,Xinhua Xiao,Gen Takayanagi,Yi Wang
Journal of Diabetes Investigation. 2020;
[Pubmed] | [DOI]
42 Coumarin-chalcone hybrids targeting insulin receptor: Design, synthesis, anti-diabetic activity, and molecular docking
Sathish Kumar Konidala,Vijay Kotra,Ravi Chandra Sekhara Reddy Danduga,Phani Kumar Kola
Bioorganic Chemistry. 2020; 104: 104207
[Pubmed] | [DOI]
43 Probiotics ameliorate pioglitazone-associated bone loss in diabetic rats
Ahmad Gholami,Mohammad Hossein Dabbaghmanesh,Younes Ghasemi,Pedram Talezadeh,Farhad Koohpeyma,Nima Montazeri-Najafabady
Diabetology & Metabolic Syndrome. 2020; 12(1)
[Pubmed] | [DOI]
44 Subclinical macro and microvascular disease is differently associated with depressive symptoms in men and women: Findings from the SABRE population-based study
Jingyi Wang,Therese Tillin,Alun D. Hughes,Marcus Richards,Naveed Sattar,Chloe Park,Nish Chaturvedi
Atherosclerosis. 2020; 312: 35
[Pubmed] | [DOI]
45 Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II
Jocelyn J. Drinkwater,Timothy M. E. Davis,Valentina Hellbusch,Angus W. Turner,David G. Bruce,Wendy A. Davis
Cardiovascular Diabetology. 2020; 19(1)
[Pubmed] | [DOI]
46 Prognosis of Diabetic Peripheral Neuropathy via Decomposed Digital Volume Pulse from the Fingertip
Hai-Cheng Wei,Wen-Rui Hu,Na Ta,Ming-Xia Xiao,Xiao-Jing Tang,Hsien-Tsai Wu
Entropy. 2020; 22(7): 754
[Pubmed] | [DOI]
47 Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function
Liliane Silvano Araújo,Marcos Vinícius da Silva,Crislaine Aparecida da Silva,Maria de Fátima Borges,Heloísa Marcelina da Cunha Palhares,Laura Penna Rocha,Rosana Rosa Miranda Corrêa,Virmondes Rodrigues Júnior,Marlene Antônia dos Reis,Juliana Reis Machado,Partha Mukhopadhyay
PLOS ONE. 2020; 15(3): e0229765
[Pubmed] | [DOI]
48 Exposure to Chinese Famine in Fetal Life and the Risk of Dysglycemiain Adulthood
Yan Zhang,Chao Song,Meng Wang,Weiyan Gong,Yanning Ma,Zheng Chen,Ganyu Feng,Rui Wang,Hongyun Fang,Jing Fan,Ailing Liu
International Journal of Environmental Research and Public Health. 2020; 17(7): 2210
[Pubmed] | [DOI]
49 NF-?B gene expression in peripheral blood and urine in early diagnosis of diabetic nephropathy – a liquid biopsy approach
Glaucia Luciano da Veiga,Matheus Gonçalves Della Nina Raffo,Beatriz da Costa Aguiar Alves,Marcelo Rodrigues Bacci,Fernando Luiz Affonso Fonseca
URINE. 2020;
[Pubmed] | [DOI]

Integrated Datasets of Proteomic and Metabolomic Biomarkers to Predict Its Impacts on Comorbidities of Type 2 Diabetes Mellitus

Amrita K. K. Cheema,Prabhjit Kaur,Amena Fadel,Noura Younes,Mahmoud Zirie,Nasser M Rizk
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 2409
[Pubmed] | [DOI]
51 Acute and chronic diabetes complications associated with self-reported oral health: a retrospective cohort study
Kamini Kaura Parbhakar,Laura C. Rosella,Sonica Singhal,Carlos R. Quiñonez
BMC Oral Health. 2020; 20(1)
[Pubmed] | [DOI]
52 The impact of diabetes mellitus on health-related quality of life in Saudi Arabia
Diena M. Almasri,Ahmad O. Noor,Ragia H. Ghoneim,Alaa A. Bagalagel,Mansour Almetwazi,Nujud A. Baghlaf,Esraa A. Hamdi
Saudi Pharmaceutical Journal. 2020;
[Pubmed] | [DOI]
53 Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities
Nidhi Raval,Akshant Kumawat,Dnyaneshwar Kalyane,Kiran Kalia,Rakesh K. Tekade
Drug Discovery Today. 2020;
[Pubmed] | [DOI]
54 Antidiabetic Potential of Prosopis farcta Roots: In Vitro Pancreatic Beta Cell Protection, Enhancement of Glucose Consumption, and Bioassay-Guided Fractionation
Behzad Shahbazi,Saba Feyzmand,Fataneh Jafari,Nastaran Ghiasvand,Gholamreza Bahrami,Ali Fattahi,Solomon Habtemariam,Seyed-Mohammad Nabavi,Yalda Shokoohinia
Evidence-Based Complementary and Alternative Medicine. 2020; 2020: 1
[Pubmed] | [DOI]

Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study

Roqayeh Aliyari,Ebrahim Hajizadeh,Ashraf Aminorroaya,Farshad Sharifi,Iraj Kazemi,Ahmad-Reza Baghestani
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020; Volume 13: 1863
[Pubmed] | [DOI]
56 Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus
Nasim Sohrabifar,Sayyed Mohammad Hossein Ghaderian,Saeed Alipour Para,Hamid Ghaedi,Hossein Jafari
Archives of Physiology and Biochemistry. 2020; : 1
[Pubmed] | [DOI]

Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-?B and TGF-ß1/Smad3 Signaling Pathways in Diabetic Nephropathy

Zhi-chao Zheng,Wei Zhu,Lei Lei,Xue-qi Liu,Yong-gui Wu
Drug Design, Development and Therapy. 2020; Volume 14: 4135
[Pubmed] | [DOI]
58 Autoimmune Thyroid Disease is Associated with a Lower Prevalence of Diabetic Retinopathy in Patients with Type 1 Diabetic Mellitus
Magdalena Maria Stefanowicz-Rutkowska,Wojciech Matuszewski,Elzbieta Maria Bandurska-Stankiewicz
Medicina. 2020; 56(6): 255
[Pubmed] | [DOI]
59 Palbinone alleviates diabetic retinopathy in STZ-induced rats by inhibiting NLRP3 inflammatory activity
Qiang Shi,Jianchao Wang,Yuhong Cheng,Xiaomin Dong,Ming Zhang,Cheng Pei
Journal of Biochemical and Molecular Toxicology. 2020; : e22489
[Pubmed] | [DOI]
60 Dynamic Phenotypes and Molecular Mechanisms to Understand the Pathogenesis of Diabetic Nephropathy in Two Widely Used Animal Models of Type 2 Diabetes Mellitus
Yanfei Liu,Hui Huang,Rui Gao,Yue Liu
Frontiers in Cell and Developmental Biology. 2020; 8
[Pubmed] | [DOI]
61 Crassocephalum rubens (Juss. Ex Jacq.) S. Moore improves pancreatic histology, insulin secretion, liver and kidney functions and ameliorates oxidative stress in fructose-streptozotocin induced type 2 diabetic rats
Olajumoke A. Oyebode,Ochuko L. Erukainure,Olakunle Sanni,Md.Shahidul Islam
Drug and Chemical Toxicology. 2020; : 1
[Pubmed] | [DOI]
62 Assessment of Drug Therapy Problems Among Type 2 Diabetes Patients with Hypertension Comorbidity in Indonesia
Julaeha Julaeha,Ery Fudjiati,Aprilita Rina Yanti Eff
Borneo Journal of Pharmacy. 2020; 3(3): 190
[Pubmed] | [DOI]
63 Screening of Antioxidant and a-Glucosidase Inhibitory Activities of Indian Medicinal Plants
Pavan K. Mujawdiya,Suman Kapur
Current Enzyme Inhibition. 2020; 16(2): 145
[Pubmed] | [DOI]
64 Asymptomatic Cardiovascular Changes and Complications in Type 2 Diabetes Mellitus
Ramakrishna Goratla,Kalyankumar P.V,Sravani K
Journal of Evidence Based Medicine and Healthcare. 2020; 7(35): 1871
[Pubmed] | [DOI]
65 The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis
Emanuel L. Peter,Prakash B. Nagendrappa,Anita Kaligirwa,Patrick Engeu Ogwang,Crispin Duncan Sesaazi
Phytotherapy Research. 2020;
[Pubmed] | [DOI]
66 Improving the endothelial dysfunction in type 2 diabetes with chromium and vitamin D3 byreducing homocysteine and oxidative stress: A randomized placebo-controlled trial
Fatemeh Imanparast,Farideh Jalali Mashayekhi,Fatemeh Kamankesh,Fatemeh Rafiei,Pegah Mohaghegh,Abbas Alimoradian
Journal of Trace Elements in Medicine and Biology. 2020; 62: 126639
[Pubmed] | [DOI]
67 Knowledge, Awareness and Prevalence of Diabetic Retinopathy among Patients of Type 2 Diabetes Mellitus on Their First Visit to Eye Department in a Tertiary Health Care Centre - A Hospital Based Cross Sectional Study
Jasmita Satapathy,Anita Minj,Keya Chakrabarti,Priya Gupta
Journal of Evidence Based Medicine and Healthcare. 2020; 7(34): 1770
[Pubmed] | [DOI]
68 Assessment of treatment satisfaction and adherence amongst diabetic patients in governmental primary care clinic of Ramallah, West-Bank
Maher Khdour,Heba B. Awadallah,Dua’a H. Al-Hamed
Hospital Practice. 2020; : 1
[Pubmed] | [DOI]
69 Effect of Lactobacillus delbrueckii Subsp. lactis PTCC1057 on Serum Glucose, Fetuin-A ,and Sestrin 3 Levels in Streptozotocin-Induced Diabetic Mice
Jamal Hallajzadeh,Reza Dolatyari Eslami,Asghar Tanomand
Probiotics and Antimicrobial Proteins. 2020;
[Pubmed] | [DOI]
70 Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus
Emanuel L. Peter,Andrew G. Mtewa,Prakash B. Nagendrappa,Anita Kaligirwa,Crispin Duncan Sesaazi
Systematic Reviews. 2020; 9(1)
[Pubmed] | [DOI]
71 Percussion Entropy Analysis of Synchronized ECG and PPG Signals as a Prognostic Indicator for Future Peripheral Neuropathy in Type 2 Diabetic Subjects
Hai-Cheng Wei,Na Ta,Wen-Rui Hu,Sheng-Ying Wang,Ming-Xia Xiao,Xiao-Jing Tang,Jian-Jung Chen,Hsien-Tsai Wu
Diagnostics. 2020; 10(1): 32
[Pubmed] | [DOI]
72 Effects of a high concentration of hydrogen on neurological function after traumatic brain injury in diabetic rats
Ting-Ting Li,Wan-Chao Yang,Yue-Zhen Wang,Tian Sun,Hong-Ling Cao,Jian-Feng Chen,Wen-Zhi Li
Brain Research. 2020; : 146651
[Pubmed] | [DOI]
73 Real-World Clinical Effectiveness and Tolerability of Hydroxychloroquine 400 Mg in Uncontrolled Type 2 Diabetes Subjects who are not Willing to Initiate Insulin Therapy (HYQ-Real-World Study)
Amit Gupta
Current Diabetes Reviews. 2019; 15(6): 510
[Pubmed] | [DOI]
74 Dendrimer Based Nanoarchitectures in Diabetes Management: An Overview
Vijay Mishra,Nishika Yadav,Gaurav K. Saraogi,Murtaza M. Tambuwala,Namita Giri
Current Pharmaceutical Design. 2019; 25(23): 2569
[Pubmed] | [DOI]
75 Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events
Stjepan Šimic,Tomo Svaguša,Ingrid Prkacin,Tomislav Bulum
Journal of Diabetes & Metabolic Disorders. 2019;
[Pubmed] | [DOI]
76 In-Vitro Antioxidant, Hypoglycemic Activity, and Identification of Bioactive Compounds in Phenol-Rich Extract from the Marine Red Algae Gracilaria edulis (Gmelin) Silva
Mišo Gunathilaka,Mišo Samarakoon,Mišo Ranasinghe,Mišo Peiris
Molecules. 2019; 24(20): 3708
[Pubmed] | [DOI]
77 Synergistic Anti-diabetic Activity of Gongronema latifolium and Telfairia occidentalis Leaves Extracts on Hepatic Function and Hematological Indices in Wistar Rats
Paulinus Mfon Udoudoh,Daniel Ejim Uti,Emmanuel E. Edet,Sunday Nkereuwem Etukudoh,Blessing Godwin Ukwak,Uket Nta Obeten,Grace Ufedo Umoru
Asian Journal of Biological Sciences. 2019; 13(1): 42
[Pubmed] | [DOI]
Payal Mukker,Kala Syamala Kumari Narayanan
Journal of Evidence Based Medicine and Healthcare. 2019; 6(15): 1177
[Pubmed] | [DOI]
79 Targeted screening for prediabetes and undiagnosed diabetes in a community setting in India
Thirunavukkarasu Sathish,Jonathan Shaw,Robyn J. Tapp,Rory Wolfe,Kavumpurathu R. Thankappan,Sajitha Balachandran,Brian Oldenburg
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;
[Pubmed] | [DOI]
80 Pharmacist-led interventional programs for diabetic patients in Arab countries: A systematic review study
Ehab Mudher Mikhael,Mohamed Azmi Hassali,Saad Abdulrahman Hussain,Ahmed Ibrahim Nouri,Nizar Shawky
International Journal of Diabetes in Developing Countries. 2019;
[Pubmed] | [DOI]
81 Mechanisms Involved in Glycemic Control Promoted by Exercise in Diabetics
Eric Francelino Andrade,Víviam de Oliveira Silva,Débora Ribeiro Orlando,Luciano José Pereira
Current Diabetes Reviews. 2019; 15(2): 105
[Pubmed] | [DOI]
82 Aqueous leaf extract of Clinacanthus nutans improved metabolic indices and sorbitol-related complications in type II diabetic rats (T2D)
Mustapha Umar Imam,Maznah Ismail,Annie George,Sasikala M. Chinnappan,Ashril Yusof
Food Science & Nutrition. 2019;
[Pubmed] | [DOI]
83 Randomized Controlled Trial of Physical Exercise in Diabetic Veterans With Length-Dependent Distal Symmetric Polyneuropathy
Evan B. Stubbs,Morris A. Fisher,Clara M. Miller,Christine Jelinek,Jolene Butler,Conor McBurney,Eileen G. Collins
Frontiers in Neuroscience. 2019; 13
[Pubmed] | [DOI]
84 Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis
Jing Liu,Caiying Li,Wen Chen,Kuanrong He,Huijuan Ma,Boqing Ma,Pei Zhao,Lu Tian
BioMed Research International. 2019; 2019: 1
[Pubmed] | [DOI]
85 The prevalence of macro and microvascular complications of DM among patients in Ethiopia 1990–2017: Systematic review
Bayu Begashaw Bekele
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019; 13(1): 672
[Pubmed] | [DOI]
86 The association between near-infrared spectroscopy-derived and flow-mediated dilation assessment of vascular responsiveness in the arm
Rogerio N. Soares,Yasina B. Somani,David N. Proctor,Juan M. Murias
Microvascular Research. 2019; 122: 41
[Pubmed] | [DOI]
87 Promising effects of ß-glucans on glyceamic control in diabetes
Rukiye Bozbulut,Nevin Sanlier
Trends in Food Science & Technology. 2019; 83: 159
[Pubmed] | [DOI]
Karan Naresh Amin,Elango Bhakkiyalakshmi,Jayasuriya Ravichandran,D.V.L. Sarada,Ramkumar Kunka Mohanram
Pharmacological Research. 2019; : 104601
[Pubmed] | [DOI]
89 A systematic review and meta-analysis on the efficacy and safety of traditional Chinese patent medicine Jinqi Jiangtang Tablet in the treatment of type 2 diabetes
Huijuan Gao,Yingxi Yang,Jianqing Deng,Jiaqi Liang,Weihua Zhang,Xingzhong Feng
Complementary Therapies in Medicine. 2019;
[Pubmed] | [DOI]
90 The Burden of Undiagnosed Diabetes Mellitus in Adult African Population: A Systematic Review and Meta-Analysis
Daniel Asmelash,Yemane Asmelash
Journal of Diabetes Research. 2019; 2019: 1
[Pubmed] | [DOI]
91 A therapeutic approach towards microRNA29 family in vascular diabetic complications: A boon or curse?
Aishwarya P. Dasare,Piyush Gondaliya,Akshay Srivastava,Kiran Kalia
Journal of Diabetes & Metabolic Disorders. 2019;
[Pubmed] | [DOI]
92 Therapeutic experience of saxagliptin as first add-on after metformin in Indian type 2 diabetes patients: A non-interventional, prospective, observational study (ONTARGET-INDIA)
Sanjay Kalra,Sarita Bajaj,AG Unnikrishnan,ManashP Baruah,Rakesh Sahay,V Hardik,Amit Kumar
Indian Journal of Endocrinology and Metabolism. 2019; 23(3): 312
[Pubmed] | [DOI]
93 Effect of amodiaquine on the pharmacokinetics of gliclazide in diabetic subjects
Godwin Ishaku Sambo,Taibat Bakare-Odunola Mojirade,Musa Aminu,Adamu Yakasai Ibrahim,Garba Magaji,Adzu Bulus
African Journal of Pharmacy and Pharmacology. 2019; 13(11): 139
[Pubmed] | [DOI]
94 Macro- and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh
Afsana Afroz,Wen Zhang,Andre Jin Wei Loh,Darryl Xing Jie Lee,Baki Billah
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;
[Pubmed] | [DOI]
95 Diabetic foot – invalidating complication of diabetes mellitus
Oana Manuela Spalatelu,Sergiu Chirila,Leonard Gurgas,Vasile Sârbu
Medic.ro. 2019; 129 (3)(1): 40
[Pubmed] | [DOI]
96 Purine metabolites can indicate diabetes progression
Yogaraje Gowda C. Varadaiah,Senthilkumar Sivanesan,Shivananda B. Nayak,Kashinath R. Thirumalarao
Archives of Physiology and Biochemistry. 2019; : 1
[Pubmed] | [DOI]
97 Effect of Rosmarinic Acid and Sinapic Acid on Oxidative Stress Parameters in the Cardiac Tissue and Serum of Type 2 Diabetic Female Rats
Maria Zych,Weronika Wojnar,Slawomir Borymski,Katarzyna Szalabska,Piotr Bramora,Ilona Kaczmarczyk-Sedlak
Antioxidants. 2019; 8(12): 579
[Pubmed] | [DOI]
98 Improved quality of diabetes control reduces complication costs in Bulgaria
Konstantin Tachkov,Konstantin Mitov,Zornitsa Mitkova,Maria Kamusheva,Maria Dimitrova,Valentina Petkova,Alexandra Savova,Miglena Doneva,Dimitar Tcarukciev,Vasil Valov,Galia Angelova,Manoela Manova,Guenka Petrova
Biotechnology & Biotechnological Equipment. 2019; 33(1): 814
[Pubmed] | [DOI]
99 Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications
Eman Mounir Sherif,Abeer Ahmed Abd El Maksood,Omneya Ibrahim Youssef,Nouran Yousef Salah El-Din,Ola Khaled Mohamed Khater
Journal of Diabetes and its Complications. 2019;
[Pubmed] | [DOI]
100 A systematic review on the mechanisms of vitamin K effects on the complications of diabetes and pre-diabetes
Nahid Karamzad,Vahid Maleki,Kristin Carson-Chahhoud,Samaneh Azizi,Amirhossein Sahebkar,Bahram Pourghassem Gargari
BioFactors. 2019;
[Pubmed] | [DOI]
101 Is it necessary to screen patient with adhesive capsulitis of shoulder for diabetes mellitus?
SK Rai,Manoj Kashid,Barun Chakrabarty,Vimal Upreti,Omna Shaki
Journal of Family Medicine and Primary Care. 2019; 8(9): 2927
[Pubmed] | [DOI]
102 Effects of Moringa oleifera on oxidative stress, apoptotic and inflammatory biomarkers in streptozotocin-induced diabetic animal model
O.O. Oguntibeju,G.Y. Aboua,E.I. Omodanisi
South African Journal of Botany. 2019;
[Pubmed] | [DOI]
103 Effects of Allium tuncelianum on oxidative stress and hyperglycemia in rats with diabetes mellitus induced by streptozotocin
Gözde Atilla,Ali Bilgili,Hamit Uslu,Dinçer Erdag,Oktay Özkan
Ankara Üniversitesi Veteriner Fakültesi Dergisi. 2019;
[Pubmed] | [DOI]
104 Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism
Kamesh Venkatakrishnan,Hui-Fang Chiu,Chin-Kun Wang
Journal of Functional Foods. 2019; 57: 425
[Pubmed] | [DOI]
105 Dietary patterns and management of type 2 diabetes: A systematic review of randomised clinical trials
D. Papamichou,D.B. Panagiotakos,C. Itsiopoulos
Nutrition, Metabolism and Cardiovascular Diseases. 2019;
[Pubmed] | [DOI]
106 Foot Kinetic and Kinematic Profile in Type 2 Diabetes Mellitus with Peripheral Neuropathy
Animesh Hazari,Arun G. Maiya,K.N. Shivashankara
Journal of the American Podiatric Medical Association. 2019; 109(1): 36
[Pubmed] | [DOI]
107 Association of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic vascular complications in type 2 diabetes mellitus
Agnieszka Gala-Bladzinska,Joanna Czech,Marcin Braun,Marzena Skrzypa,Krzysztof Gargasz,Artur Mazur,Izabela Zawlik
Advances in Medical Sciences. 2019; 64(1): 137
[Pubmed] | [DOI]
108 Prevalence of Type 1 and Type 2 Diabetes-Related Complications and Their Association With Determinants Identified in Canada’s Survey on Living With Chronic Diseases—Diabetes Component
Mohsen Yaghoubi,Kerry Mansell,Hassanali Vatanparast,Megan Steeves,Wu Zeng,Marwa Farag
Canadian Journal of Diabetes. 2019;
[Pubmed] | [DOI]
109 TRACK (by NEHEP) Implementation: A Bangladesh Scenario
Abdul Kader Mohiuddin
Pharmacovigilance and Pharmacoepidemiology. 2019; : 28
[Pubmed] | [DOI]
110 Endoplasmic Reticulum Stress: A Critical Molecular Driver of Endothelial Dysfunction and Cardiovascular Disturbances Associated with Diabetes
Hatem Maamoun,Shahenda Abdelsalam,Asad Zeidan,Hesham Korashy,Abdelali Agouni
International Journal of Molecular Sciences. 2019; 20(7): 1658
[Pubmed] | [DOI]
111 Frequency of Diabetes Foot Ulcer and Related Factors Among Adult Diabetic Patients in the Diabetes Center of Kerman, Iran
Ali Khalooei,Mansour Mahmoodi Meymand
Shiraz E-Medical Journal. 2019; In Press(In Press)
[Pubmed] | [DOI]
112 Digital Volume Pulse Measured at the Fingertip as an Indicator of Diabetic Peripheral Neuropathy in the Aged and Diabetic
Hai-Cheng Wei,Na Ta,Wen-Rui Hu,Ming-Xia Xiao,Xiao-Jing Tang,Bagus Haryadi,Juin J. Liou,Hsien-Tsai Wu
Entropy. 2019; 21(12): 1229
[Pubmed] | [DOI]
113 Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study
Michele Colaci,Dilia Giuggioli,Amelia Spinella,Caterina Vacchi,Federica Lumetti,Anna Vittoria Mattioli,Francesca Coppi,Vincenzo Aiello,Maria Perticone,Lorenzo Malatino,Clodoveo Ferri
Clinical Rheumatology. 2019;
[Pubmed] | [DOI]
114 Economic Impact of Diabetes in Africa
Clarisse Mapa-Tassou,Jean-Claude Katte,Camille Mba Maadjhou,Jean Claude Mbanya
Current Diabetes Reports. 2019; 19(2)
[Pubmed] | [DOI]
115 From Table to Stable: A Comparative Review of Selected Aspects of Human and Equine Metabolic Syndrome
Valentina M. Ragno,Gordon A. Zello,Colby D. Klein,Julia B. Montgomery
Journal of Equine Veterinary Science. 2019; 79: 131
[Pubmed] | [DOI]
116 Molecular Concept of Diabetic Wound Healing: Effective Role of Herbal Remedies
Amro Mohamed Soliman,Seong Lin Teoh,Norzana Abd Ghafar,Srijit Das
Mini-Reviews in Medicinal Chemistry. 2019; 19(5): 381
[Pubmed] | [DOI]
117 Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease
Jia Guo,Zhangsuo Liu,Rujun Gong
Clinical Science. 2019; 133(12): 1321
[Pubmed] | [DOI]
118 Evaluation of long-term intravitreal anti-vascular endothelial growth factor injections on renal function in patients with and without diabetic kidney disease
Rachael Ann O’Neill,Patrick Gallagher,Tricia Douglas,Julie-Anne Little,Alexander Peter Maxwell,Giuliana Silvestri,Gareth McKay
BMC Nephrology. 2019; 20(1)
[Pubmed] | [DOI]
119 The Impact of a Community-Based Food Education Program on Nutrition-Related Knowledge in Middle-Aged and Older Patients with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial
Carlos Vasconcelos,António Almeida,Maria Cabral,Elisabete Ramos,Romeu Mendes
International Journal of Environmental Research and Public Health. 2019; 16(13): 2403
[Pubmed] | [DOI]
120 Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study
Richard Ofori-Asenso,Danny Liew,Samanta Lalic,Mohsen Mazidi,Dianna J. Magliano,Zanfina Ademi,J. Simon Bell,Jenni Ilomaki
Advances in Therapy. 2019;
[Pubmed] | [DOI]
121 DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment
Momir Mikov,Nebojša Pavlovic,Bojan Stanimirov,Maja Ðanic,Svetlana Golocorbin-Kon,Karmen Stankov,Hani Al-Salami
European Journal of Drug Metabolism and Pharmacokinetics. 2019;
[Pubmed] | [DOI]
122 The Role of Protein Tyrosine Phosphatase (PTP)-1B in Cardiovascular Disease and Its Interplay with Insulin Resistance
Amirhossein Abdelsalam,Amirhossein Korashy,Amirhossein Zeidan,Amirhossein Agouni
Biomolecules. 2019; 9(7): 286
[Pubmed] | [DOI]
123 Automatically Extracting Disease-Disease Association from Literature with a Large Margin Context-Aware Convolutional Neural Network (Preprint)
Po-Ting Lai,Wei-Liang Lu,Ting-Rung Kuo,Chia-Ru Chung,Jen-Chieh Han,Richard Tzong-Han Tsai,Jorng-Tzong Horng
JMIR Medical Informatics. 2019;
[Pubmed] | [DOI]
124 Understanding the multifaceted mechanisms of diabetic wound healing and therapeutic application of stem cells conditioned medium in the healing process
Lai Woon Fui,Michael Phang Weng Lok,Vijayendran Govindasamy,Then Kong Yong,Then Khong Lek,Anjan Kumar Das
Journal of Tissue Engineering and Regenerative Medicine. 2019;
[Pubmed] | [DOI]
125 Effects of Turmeric ( Curcuma longa) Extract in streptozocin-induced diabetic model
Rana Essa,Ahmed M. El Sadek,Marine E. Baset,Mohamed A. Rawash,Diana G. Sami,Marwa T. Badawy,Maha E. Mansour,Hamdino Attia,Mona K. Saadeldin,Ahmed Abdellatif
Journal of Food Biochemistry. 2019;
[Pubmed] | [DOI]
126 Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients
Zeynep Mine Coskun,Melike Ersoz,Mine Adas,Veysel Sabri Hancer,Serife Nur Boysan,Mustafa Sait Gonen,Aynur Acar
Archives of Medical Research. 2019; 50(3): 91
[Pubmed] | [DOI]
127 Use of Dapagliflozin in the Management of Type 2 Diabetes Mellitus: A Real-World Evidence Study in Indian Patients (FOREFRONT)
Vijay Viswanathan,K.P. Singh
Diabetes Technology & Therapeutics. 2019; 21(8): 415
[Pubmed] | [DOI]
128 Higher Levels of ANGPTL5 in the Circulation of Subjects With Obesity and Type 2 Diabetes Are Associated With Insulin Resistance
Ghazi Alghanim,Mohamed G. Qaddoumi,Nouf Alhasawi,Preethi Cherian,Irina Al-Khairi,Rasheeba Nizam,Fadi Alkayal,Muath Alanbaei,Jaakko Tuomilehto,Jehad Abubaker,Mohamed Abu-Farha,Fahd Al-Mulla
Frontiers in Endocrinology. 2019; 10
[Pubmed] | [DOI]
129 Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus
Weiyue Zhang,Juan Zheng,Xiang Hu,Lulu Chen
Endocrine. 2019;
[Pubmed] | [DOI]
130 Homocysteine, interleukin-1ß, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness
Zhenxiang Dai,Yang Jiao,Qingxian Fan,Anning Qi,Liang Xiao,Jingwei Li
Experimental and Therapeutic Medicine. 2019;
[Pubmed] | [DOI]
131 Effect of resveratrol on dipeptidyl peptidase-4 inhibitors pharmacokinetics: An in vitro and in vivo approach
Shruti Surendran,Rekha Sapkal,David Paul,Satheeshkumar Nanjappan
Chemico-Biological Interactions. 2019; : 108909
[Pubmed] | [DOI]
132 Diabetic Vascular Damage: Review of Pathogenesis and Possible Evaluation Technologies
Sergej Sosunkevic,Andrius Rapalis,Mindaugas Marozas,Jonas Ceponis,Arunas Lukosevicius
IEEE Access. 2019; 7: 148511
[Pubmed] | [DOI]
133 Acute cardiovascular complications in patients with diabetes and hypertension: management consideration for minor oral surgery
Ajinath Nanasaheb Jadhav,Pooja Raosaheb Tarte
Journal of the Korean Association of Oral and Maxillofacial Surgeons. 2019; 45(4): 207
[Pubmed] | [DOI]
134 Prediction of stump healing in lower limb amputation: a narrative review
Suhel Ashraff,Muhammad A Siddiqui,Derek Santos,Thomas Carline
Journal of Wound Care. 2019; 28(Sup12): S18
[Pubmed] | [DOI]
135 Estimation of Aldose Reductase Activity and Malondialdehyde Levels in Patients with Type 2 Diabetes Mellitus
Sandeep Kumar,Ajay Kumar,Mohammad Mustufa Khan
Biomedical and Pharmacology Journal. 2019; 12(2): 1001
[Pubmed] | [DOI]
136 Myricetin ameliorates high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells
Azadeh Aminzadeh,Hamideh Bashiri
Cell Biochemistry and Function. 2019;
[Pubmed] | [DOI]
137 VEGF-A and cardiac autonomic function in newly diagnosed type 2 diabetes mellitus: A cross-sectional study at a tertiary care center
Suresh Ravichandran,Shival Srivastav,PrathameshHaridas Kamble,Shailja Chambial,Ravindra Shukla,Praveen Sharma,RajeshKumar Sharma
Journal of Family Medicine and Primary Care. 2019; 8(10): 3185
[Pubmed] | [DOI]
138 The major molecular mechanisms mediating the renoprotective effects of SGLT2 inhibitors: An update
Habib Yaribeygi,Luis E. Simental-Mendía,Maciej Banach,Simona Bo,Amirhossein Sahebkar
Biomedicine & Pharmacotherapy. 2019; 120: 109526
[Pubmed] | [DOI]
139 Antioxidant and Anti-Inflammatory Effects of Curcumin Nanoparticles on Drug-Induced Acute Myocardial Infarction in Diabetic Rats
Asma Boarescu,Asma Boarescu,Asma Boc?an,Asma Gheban,Asma Bulboaca,Asma Nicula,Asma Pop,Asma Râjnoveanu,Asma Bolboaca
Antioxidants. 2019; 8(10): 504
[Pubmed] | [DOI]
140 A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes
Sharon Mitchell,Belma Malanda,Albertino Damasceno,Robert H. Eckel,Dan Gaita,Kornelia Kotseva,James L. Januzzi,George Mensah,Jorge Plutzky,Maksym Prystupiuk,Lars Ryden,Jorge Thierer,Salim S. Virani,Laurence Sperling
Global Heart. 2019; 14(3): 215
[Pubmed] | [DOI]
141 Flavonoids and Their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels
Asma AL-Ishaq,Asma Abotaleb,Asma Kubatka,Asma Kajo,Asma Büsselberg
Biomolecules. 2019; 9(9): 430
[Pubmed] | [DOI]
142 Novel Hybrids of Pyrazolidinedione and Benzothiazole as TZD Analogues. Rationale Design, Synthesis and In Vivo Anti-Diabetic Evaluation
Michelyne Haroun
Medicinal Chemistry. 2019; 15(6): 624
[Pubmed] | [DOI]
143 Dietary antioxidant for disease prevention corroborated by the Nrf2 pathway
Amany M. Hegazy,Eman M. El-Sayed,Khadiga S. Ibrahim,Amal S. Abdel-Azeem
Journal of Complementary and Integrative Medicine. 2019; 16(3)
[Pubmed] | [DOI]
144 Patient reported experience of blood glucose management when undergoing hyperbaric oxygen treatment
Carol Baines,Geraldine O’Rourke,Charne Miller,Karen Ford,William McGuiness
Collegian. 2018;
[Pubmed] | [DOI]
145 A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes
Habib Yaribeygi,Stephen L. Atkin,Matteo Pirro,Amirhossein Sahebkar
Journal of Cellular Physiology. 2018;
[Pubmed] | [DOI]
146 Glycaemic indices and haemoglobin A1c as predictors for non-healing ulcers
Kevin J. Moore,Erin C. Dunn,Erin N. Marcus,Tulay Koru-Sengul
Journal of Wound Care. 2018; 27(Sup4): S6
[Pubmed] | [DOI]
147 Diabetic retinopathy awareness and associations with multiple comorbidities: Insights from DIAMOND Study
Kiran Shah,Alka Gandhi,Sundaram Natarajan
Indian Journal of Endocrinology and Metabolism. 2018; 22(1): 30
[Pubmed] | [DOI]
148 Endothelin-1 Regulation Is Entangled in a Complex Web of Epigenetic Mechanisms in Diabetes
Physiological Research. 2018; : S115
[Pubmed] | [DOI]
149 The effect of change in fasting glucose on the risk of myocardial infarction, stroke, and all-cause mortality: a nationwide cohort study
Gyeongsil Lee,Sung Min Kim,Seulggie Choi,Kyuwoong Kim,Su-Min Jeong,Joung Sik Son,Jae-Moon Yun,Sang Min Park
Cardiovascular Diabetology. 2018; 17(1)
[Pubmed] | [DOI]
150 GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
María Isabel del Olmo-Garcia,Juan Francisco Merino-Torres
Journal of Diabetes Research. 2018; 2018: 1
[Pubmed] | [DOI]
151 Beetle (Ulomoides dermestoides) fat improves diabetes: effect on liver and pancreatic architecture and on PPAR? expression
E.I. Jasso-Villagomez,M. Garcia-Lorenzana,J.C. Almanza-Perez,M.A. Fortis-Barrera,G. Blancas-Flores,R. Roman-Ramos,L.A. Prado-Barragan,F.J. Alarcon-Aguilar
Brazilian Journal of Medical and Biological Research. 2018; 51(6)
[Pubmed] | [DOI]
152 Altered expression of WFS1 and NOTCH2 genes associated with diabetic nephropathy in T2DM patients
Sahar A. Sharaf,Nagwa A. Kantoush,Dina F. Ayoub,Alshaymaa A. Ibrahim,Amaal A. Abdelaal,Rokaya Abdel Aziz,Mahmoud M. ElHefnawi,Amira N. Ahmed
Diabetes Research and Clinical Practice. 2018; 140: 304
[Pubmed] | [DOI]
153 Effects of High Glucose on the Expression of LAMA1 and Biological Behavior of Choroid Retinal Endothelial Cells
Guangwei Song,Da Lin,Licheng Bao,Qi Jiang,Yinan Zhang,Haihua Zheng,Qianying Gao
Journal of Diabetes Research. 2018; 2018: 1
[Pubmed] | [DOI]
154 Protective Effect of Inulin and the Integrity of the Microvasculature in Diabetes Mellitus
Wassef Girgiss Nicola,Mina Wassef Girgiss,Aly Mohamed Ezz El-Arab,Dawoud Fakhry Habib,Mohamed qElsayed Elnemr,Nadia Mohamed Ahmed,Eman Refaat Youness
Biomedical and Pharmacology Journal. 2018; 11(2): 807
[Pubmed] | [DOI]
155 Toll-Like Receptor 4 and Heat-Shock Protein 70: Is it a New Target Pathway for Diabetic Vasculopathies?
Amanda Almeida de Oliveira,R. Clinton Webb,Kenia Pedrosa Nunes
Current Drug Targets. 2018; 20(1): 51
[Pubmed] | [DOI]
156 The impact of diabetes on treatment in general dental practice
Vinson Yeung,Joht Chandan
Dental Update. 2018; 45(2): 120
[Pubmed] | [DOI]
157 Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection—The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress
Nabeel Quryshi,Laura Norwood Toro,Karima Ait-Aissa,Amanda Kong,Andreas Beyer
International Journal of Molecular Sciences. 2018; 19(3): 797
[Pubmed] | [DOI]
158 The Big Entity of New RNA World: Long Non-Coding RNAs in Microvascular Complications of Diabetes
Satish K. Raut,Madhu Khullar
Frontiers in Endocrinology. 2018; 9
[Pubmed] | [DOI]
159 Synthesis of newly functionalized 1,4-naphthoquinone derivatives and their effects on wound healing in alloxan-induced diabetic mice
Silvia Helena Cardoso,Cleidijane Rodrigues de Oliveira,Ari Souza Guimarães,Jadiely Nascimento,Julianderson de Oliveira dos Santos Carmo,Jamylle Nunes de Souza Ferro,Ana Carolina de Carvalho Correia,Emiliano Barreto
Chemico-Biological Interactions. 2018; 291: 55
[Pubmed] | [DOI]
160 Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
Corey J. Lager,Nazanene H. Esfandiari,Yingying Luo,Angela R. Subauste,Andrew T. Kraftson,Morton B. Brown,Oliver A. Varban,Rasimcan Meral,Ruth B. Cassidy,Catherine K. Nay,Amy L. Lockwood,Darlene Bellers,Colleen M. Buda,Elif A. Oral
Obesity Surgery. 2018;
[Pubmed] | [DOI]
161 There is a positive association between vitamin B12 deficiency and serum total cholesterol in Iranian type 2 diabetic patients on Metformin
Mitra Niafar,Golnaz Samadi,Naser Aghamohammadzadeh,Farzad Najafipour,Zeinab Nikniaz
Nutrition Clinique et Métabolisme. 2018;
[Pubmed] | [DOI]
162 ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus
Cheng Liu,Yanfang Li,Tianwang Guan,Yanxian Lai,Yan Shen,Abudurexiti Zeyaweiding,Haiyan Zhao,Fang Li,Tutiguli Maimaiti
Cardiovascular Diabetology. 2018; 17(1)
[Pubmed] | [DOI]
163 BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability
Naoufal Akla,Claire Viallard,Natalija Popovic,Cindy Lora Gil,Przemyslaw Sapieha,Bruno Larrivée
Arteriosclerosis, Thrombosis, and Vascular Biology. 2018; 38(8): 1821
[Pubmed] | [DOI]
164 Importance and Potential of Dentists in Identifying Patients at High Risk of Diabetes
Siddardha G. Chandrupatla,Ranadheer Ramachandra,Satyanarayana Dantala,Krishnappa Pushpanjali,Mary Tavares
Current Diabetes Reviews. 2018; 15(1): 67
[Pubmed] | [DOI]
165 Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy
Kuppuswami Jayashree,Md. Yasir,Gandhipuram Periyasamy Senthilkumar,K Ramesh Babu,Vadivelan Mehalingam,Palani Selvam Mohanraj
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2018;
[Pubmed] | [DOI]
166 A new indanedione derivative alleviates symptoms of diabetes by modulating RAGE-NF-kappaB pathway in db/db mice
Gulnaz Khan,Meha Fatima Aftab,Bilquees Bano,Khalid Mohammed Khan,Munazza Murtaza,Sonia Siddiqui,M.Hafizur Rehman,Rizwana Sanaullah Waraich
Biochemical and Biophysical Research Communications. 2018;
[Pubmed] | [DOI]
167 Investigation of effects of neurotrophic factors on painful diabetic neuropathy: an experimental study
Faruk Kilinç,Ramis Çolak,Mete Özcan,Ahmet Ayar
The European Research Journal. 2018;
[Pubmed] | [DOI]
168 Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension
Morgan E. Whitaker,Vineet Nair,Shripad Sinari,Parinita Dherange,Balaji Natarajan,Lindsey Trutter,Evan L. Brittain,Anna R. Hemnes,Eric Austin,Kumar Patel,Stephen M. Black,Joe G.N. Garcia,Jason X. Yuan,Rebecca Vanderpool,Franz Rischard,Ayako Makino,Edward J. Bedrick,Ankit A. Desai
The American Journal of Medicine. 2018;
[Pubmed] | [DOI]
169 Potential of traditionally consumed medicinal herbs, spices, and food plants to inhibit key digestive enzymes geared towards diabetes mellitus management — A systematic review
A.D. Seetaloo,M.Z. Aumeeruddy,R.R. Rengasamy Kannan,M.F. Mahomoodally
South African Journal of Botany. 2018;
[Pubmed] | [DOI]
170 Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients
Sivanandy Palanisamy,Emily Yien,Ling Shi,Low Si,See Qi,Laura Ling,Teng Lun,Yap Chen
Pharmacy. 2018; 6(3): 57
[Pubmed] | [DOI]
171 The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters
Khalid Al-Rubeaan,Khalid Siddiqui,Mohammed A. Al-Ghonaim,Amira M. Youssef,Dhekra AlNaqeeb
Annals of Saudi Medicine. 2018; 38(1): 46
[Pubmed] | [DOI]
172 Glycerol dehydration of native and diabetic animal tissues studied by THz-TDS and NMR methods
O. A. Smolyanskaya,I. J. Schelkanova,M. S. Kulya,E. L. Odlyanitskiy,I. S. Goryachev,A. N. Tcypkin,Ya. V. Grachev,Ya. G. Toropova,V. V. Tuchin
Biomedical Optics Express. 2018; 9(3): 1198
[Pubmed] | [DOI]
173 Inhibition of macrophage inflammatory protein-1ß improves endothelial progenitor cell function and ischemia-induced angiogenesis in diabetes
Ting-Ting Chang,Liang-Yu Lin,Jaw-Wen Chen
Angiogenesis. 2018;
[Pubmed] | [DOI]
174 Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall
Mojca Lunder,Miodrag Janic,Mišo Šabovic
Current Vascular Pharmacology. 2018; 17(1): 6
[Pubmed] | [DOI]
175 Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling
Bessi Qorri,Regina-Veronicka Kalaydina,Aleksandra Velickovic,Yekaterina Kaplya,Alexandria Decarlo,Myron Szewczuk
Cells. 2018; 7(9): 117
[Pubmed] | [DOI]
176 Topical Application of Adelmidrol + Trans-Traumatic Acid Enhances Skin Wound Healing in a Streptozotocin-Induced Diabetic Mouse Model
Rosalba Siracusa,Daniela Impellizzeri,Marika Cordaro,Enrico Gugliandolo,Alessio F. Peritore,Rosanna Di Paola,Salvatore Cuzzocrea
Frontiers in Pharmacology. 2018; 9
[Pubmed] | [DOI]
177 Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
Habib Yaribeygi,Alexandra E. Butler,Stephen L. Atkin,Niki Katsiki,Amirhossein Sahebkar
Journal of Cellular Physiology. 2018;
[Pubmed] | [DOI]
178 Personal Health Coaching as a Type 2 Diabetes Mellitus Self-Management Strategy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meysam Pirbaglou,Joel Katz,Mehras Motamed,Sarah Pludwinski,Krista Walker,Paul Ritvo
American Journal of Health Promotion. 2018; 32(7): 1613
[Pubmed] | [DOI]
179 Downregulation of long non-coding RNAs LINC00523 and LINC00994 in type 2 diabetes in an Iranian cohort
Zahra Mansoori,Hamid Ghaedi,Mirsaber Sadatamini,Rouhollah Vahabpour,Ali Rahimipour,Mehrnoosh Shanaki,Leyla saeidi,Faranak Kazerouni
Molecular Biology Reports. 2018;
[Pubmed] | [DOI]
180 Enhanced calcium entry via activation of NOX/PKC underlies increased vasoconstriction induced by methylglyoxal
Basma G. Eid,Alaa T. Abu-Sharib,Hany M. El-Bassossy,Khadijah Balamash,Sergey V. Smirnov
Biochemical and Biophysical Research Communications. 2018;
[Pubmed] | [DOI]
181 Neuroprotective Effect of Hydroxytyrosol in Experimental Diabetic Retinopathy: Relationship with Cardiovascular Biomarkers
José Antonio González-Correa,María Dolores Rodríguez-Pérez,Lucía Márquez-Estrada,Juan Antonio López-Villodres,José Julio Reyes,Guillermo Rodriguez-Gutierrez,Juan Fernández-Bolaños,José Pedro De La Cruz
Journal of Agricultural and Food Chemistry. 2018; 66(3): 637
[Pubmed] | [DOI]
182 Association of carotid intima-media thickness with exercise tolerance test in type 2 diabetic patients
Ali Momeni,Abdolmajid Taheri,Maryam Mansuri,Ali Bazdar,Morteza Sedehi,Masoud Amiri
IJC Heart & Vasculature. 2018; 21: 74
[Pubmed] | [DOI]
183 Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China
Yizhi Pan,Tianyi Wang,Yanfang Li,Tianwang Guan,Yanxian Lai,Yan Shen,Abudurexiti Zeyaweiding,Tutiguli Maimaiti,Fang Li,Haiyan Zhao,Cheng Liu
Lipids in Health and Disease. 2018; 17(1)
[Pubmed] | [DOI]
184 Increased Prevalence of Type 2 Diabetes–Related Complications in Combined Type 2 Diabetes and Sickle Cell Trait
Sarah C. Skinner,Mor Diaw,Vincent Pialoux,Maïmouna Ndour Mbaye,Pauline Mury,Philomène Lopez,Delphine Bousquet,Fatou Gueye,Demba Diedhiou,Philippe Joly,Céline Renoux,Djiby Sow,Saliou Diop,Brigitte Ranque,Agnès Vinet,Abdoulaye Samb,Nicolas Guillot,Philippe Connes
Diabetes Care. 2018; 41(12): 2595
[Pubmed] | [DOI]
185 Analysis of inflammatory cytokine and TLR expression levels in Type 2 Diabetes with complications
Saket Gupta,Ashwini Maratha,Jakub Siednienko,Anandan Natarajan,Thusitha Gajanayake,Shu Hoashi,Sinéad Miggin
Scientific Reports. 2017; 7(1)
[Pubmed] | [DOI]
186 Significance of cardiac and iron profile alteration in diabetic patients
Nabil A. Hasona
Comparative Clinical Pathology. 2017;
[Pubmed] | [DOI]
187 Incidence of complications in young-onset diabetes: Comparing type 2 with type 1 (the young diab study)
Anandakumar Amutha,Ranjit Mohan Anjana,Ulagamathesan Venkatesan,Harish Ranjani,Ranjit Unnikrishnan,K.M. Venkat Narayan,Viswanathan Mohan,Mohammed K. Ali
Diabetes Research and Clinical Practice. 2017; 123: 1
[Pubmed] | [DOI]
188 Reduced serum milk fat globule-epidermal growth factor 8 (MFG-E8) concentrations are associated with an increased risk of microvascular complications in patients with type 2 diabetes
Guohua Sun,Juxiang Liu,Guanghao Xia,Lijuan Zhang,Yonghong Li,Zubang Zhou,Yaya LV,Suhong Wei,Jing Liu,Jinxing Quan
Clinica Chimica Acta. 2017; 466: 201
[Pubmed] | [DOI]
189 O-GlcNAc modification of Sp1 mediates hyperglycaemia-induced ICAM-1 up-regulation in endothelial cells
Yuan Zhang,Yuan Qu,Tian Niu,Haiyan Wang,Kun Liu
Biochemical and Biophysical Research Communications. 2017; 484(1): 79
[Pubmed] | [DOI]
190 Dynamics of Diabetes and Obesity: Epidemiological Perspective
Annette Boles,Ramesh Kandimalla,P. Hemachandra Reddy
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017;
[Pubmed] | [DOI]
191 Novel insights into DNA methylation and its critical implications in diabetic vascular complications
Jia Zheng,Jing Cheng,Qian Zhang,Xinhua Xiao
Bioscience Reports. 2017; 37(2)
[Pubmed] | [DOI]
192 Restoration of Impaired Metabolic Energy Balance (ATP Pool) and Tube Formation Potential of Endothelial Cells under “high glucose”, Diabetic Conditions by the Bioinorganic Polymer Polyphosphate
Xiaohong Wang,Maximilian Ackermann,Meik Neufurth,Shunfeng Wang,Qiang Li,Qingling Feng,Heinz Schröder,Werner Müller
Polymers. 2017; 9(11): 575
[Pubmed] | [DOI]
193 Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications
Wei Yang,Yun Li,Tian Tian,Li Wang,Pearl Lee,Qi Hua
BMC Endocrine Disorders. 2017; 17(1)
[Pubmed] | [DOI]
194 Epigenetics in diabetic nephropathy, immunity and metabolism
Samuel T. Keating,Janna A. van Diepen,Niels P. Riksen,Assam El-Osta
Diabetologia. 2017;
[Pubmed] | [DOI]
195 Role of protein carbonylation in diabetes
Markus Hecker,Andreas H. Wagner
Journal of Inherited Metabolic Disease. 2017;
[Pubmed] | [DOI]
196 MicroRNA and Diabetic Complications- a clinical perspective
Baoqi Fan,Andrea On Yan Luk,Juliana C.N. Chan,Ronald Ching Wan Ma
Antioxidants & Redox Signaling. 2017;
[Pubmed] | [DOI]
197 Prevalence of Osteoporosis in Type 2 Diabetes Mellitus Patients Using Dual Energy X-Ray Absorptiometry (DEXA) Scan
Shivank Prakash,Ravi. S. Jatti,Shridhar C. Ghagane,S.M. Jali,M.V. Jali
International Journal of Osteoporosis and Metabolic Disorders. 2017; 10(2): 10
[Pubmed] | [DOI]
198 Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
Cristina Mega,Edite Teixeira-de-Lemos,Rosa Fernandes,Flávio Reis
Journal of Diabetes Research. 2017; 2017: 1
[Pubmed] | [DOI]
199 Expression of JAZF1, ABCC8, KCNJ11and Notch2 genes and vitamin D receptor polymorphisms in type 2 diabetes, and their association with microvascular complications
Maha A. Rasheed,Nagwa Kantoush,Nagwa Abd El-Ghaffar,Hebatallah Farouk,Solaf Kamel,Alshaymaa Ahmed Ibrahim,Aliaa Shalaby,Eman Mahmoud,Hala M. Raslan,Omneya M. Saleh
Therapeutic Advances in Endocrinology and Metabolism. 2017; 8(6): 97
[Pubmed] | [DOI]
200 Long-term efficacy and safety of sodium-glucose cotransporter-2 inhibitors as add-on to metformin treatment in the management of type 2 diabetes mellitus
Jian Li,Yanping Gong,Chunlin Li,Yanhui Lu,Yu Liu,Yinghong Shao
Medicine. 2017; 96(27): e7201
[Pubmed] | [DOI]
201 Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation
Wenpei Chen,Xiaolan Yao,Chenghao Zhou,Ziyang Zhang,Gang Gui,Baoqin Lin
Mediators of Inflammation. 2017; 2017: 1
[Pubmed] | [DOI]
202 Mitochondrial miRNAs in diabetes: just the tip of the iceberg
Rohini Baradan,John M. Hollander,Samarjit Das
Canadian Journal of Physiology and Pharmacology. 2017; : 1
[Pubmed] | [DOI]
203 Pancreatic Elastography From Acoustic Radiation Force Impulse Imaging for Evaluation of Diabetic Microangiopathy
Yu He,Hui Wang,Xiao Ping Li,Juan-Juan Zheng,Chun-Xiang Jin
American Journal of Roentgenology. 2017; : 1
[Pubmed] | [DOI]
204 Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction
Raffaele Altara,Mauro Giordano,Einar S. Nordén,Alessandro Cataliotti,Mazen Kurdi,Saeed N. Bajestani,George W. Booz
Frontiers in Endocrinology. 2017; 8
[Pubmed] | [DOI]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

   Abstract Pathophysiologic... Intersection of ... Common Pathways ... Introduction Microvascular an... Article Figures
  In this article

 Article Access Statistics
    PDF Downloaded3960    
    Comments [Add]    
    Cited by others 204    

Recommend this journal